A comparative evaluation of sulfalene-trimethoprim and sulphormethoxine-pyrimethamine against falciparum malaria in Thailand.
D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000906:Antibodies / Q000032:analysis; D000962:Antimalarials / Q000627:therapeutic use*; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005455:Fluorescent Antibody Technique; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood / Q000150:complications; D006400:Hematocrit; D006801:Humans; D007958:Leukocyte Count; D008288:Malaria / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000302:isolation & purification; D011739:Pyrimethamine / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013785:Thailand; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000906:Antibodies; D000962:Antimalarials; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; D014295:Trimethoprim; D011739:Pyrimethamine